Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcome

Transplantation
Michel MouradVincent Haufroid

Abstract

Immunosuppressive drugs commonly used after organ transplantation to prevent acute rejection including tacrolimus, cyclosporine, sirolimus, and mycophenolic acid are characterized by a narrow therapeutic index and broad interindividual variability in their pharmacokinetics. Adequate immunosuppression aims to reach an optimal benefit-risk ratio. Therapeutic drug monitoring represents a crucial step in routine practice to maintain blood concentrations within the target window, because the bioavailability of these drugs depends on their absorption, distribution, biotransformation, and elimination. Single nucleotide polymorphisms (SNPs) in genes encoding biotransformation enzymes (CYP3A) and drug transporters (ABCB1) have opened up a promising way for the selection of individual dosages. The relationship of these SNPs with immunosuppressive drug pharmacokinetics was extensively studied after kidney, liver, heart, and lung transplantations. Patient susceptibility to nephrotoxicity in the long term was also reported in relation to some SNPs, which could allow effective assessment of individual risk and selection of treatment according to patient parameters. Further studies are needed to provide evidence that a genetic analysis combin...Continue Reading

References

Dec 1, 1992·Transplantation·A MoutabarrikS Takahara
Dec 1, 1992·Trends in Pharmacological Sciences·S CholertonJ R Idle
May 23, 1998·Annual Review of Pharmacology and Toxicology·K E Thummel, G R Wilkinson
Jan 23, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·C K AbrassC L Davis
Apr 19, 2000·Clinical Transplantation·B D KahanC T Van Buren
Aug 15, 2001·Clinical Pharmacology and Therapeutics·R B KimG R Wilkinson
May 22, 2002·Therapeutic Drug Monitoring·David I Min, Vicki L Ellingrod
Aug 22, 2002·Clinical Pharmacology and Therapeutics·Yasuo KurataKenji Otsubo
Sep 14, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ina KochLeszek Wojnowski
Jan 22, 2003·Advanced Drug Delivery Reviews·Alfred H Schinkel, Johan W Jonker
Feb 7, 2003·The New England Journal of Medicine·William E Evans, Howard L McLeod
Apr 16, 2003·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·HongXia ZhengGilbert J Burckart
Jan 30, 2004·Journal of Clinical Pharmacology·HongXia ZhengGilbert J Burckart
Apr 23, 2004·Pharmacogenomics·Hong-Guang XieGrant R Wilkinson
Apr 30, 2004·Clinical Pharmacology and Therapeutics·Dany AnglicheauPierre Marquet
May 19, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Iain A M MacPheeDavid W Holt
May 29, 2004·Pharmacogenetics·Kenneth E Thummel
Jul 17, 2004·Transplantation·Laurence Bonhomme-FaivreVéronique Picard
Jul 23, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Dario CattaneoNorberto Perico
Sep 24, 2004·Therapeutic Drug Monitoring·David I MinHoward McLeod
Feb 15, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Dany AnglicheauEric Thervet
Mar 18, 2005·Journal of the American Society of Nephrology : JASN·Ingeborg A HauserMatthias Schwab
Apr 9, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Dennis A HesselinkTeun van Gelder
Nov 8, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ian S WestleyBenedetta C Sallustio

❮ Previous
Next ❯

Citations

Feb 20, 2010·European Journal of Drug Metabolism and Pharmacokinetics·Masaki SumiAkira Yamaji
Sep 17, 2008·European Journal of Clinical Pharmacology·Anita N StumpfArmin Gerbitz
Jul 3, 2010·Therapeutics and Clinical Risk Management·Paraskevi F KatsakioriChristodoulos S Flordellis
May 19, 2010·International Journal of Medical Sciences·Paraskevi F KatsakioriChristodoulos S Flordellis
Dec 28, 2012·Clinical and Experimental Nephrology·Tadashi SofueMasakazu Kohno
Sep 17, 2013·Translational Research : the Journal of Laboratory and Clinical Medicine·Azza A K El-SheikhFrans G M Russel
Jun 19, 2012·Archives of Medical Research·Pilar García-RocaGilberto Castañeda-Hernández
Jan 12, 2016·Drug Metabolism and Personalized Therapy·Xandra García-GonzálezLuis A López-Fernández
Dec 30, 2009·Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria·B Isla TejeraA Suárez García
Mar 1, 2011·Revue de pneumologie clinique·C KnoopM Estenne
Nov 26, 2009·Neurologic Clinics·Sasa A Zivković, Hoda Abdel-Hamid
Aug 25, 2009·The Journal of Thoracic and Cardiovascular Surgery·Yosuke TanakaKenji Okada
Oct 1, 2009·British Journal of Pharmacology·Kirsi Vähäkangas, Päivi Myllynen
Jun 17, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·François GlowackiChristelle Cauffiez
Sep 5, 2009·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Laurence Bonhomme-FaivreRobert Farinotti
Mar 28, 2012·Expert Review of Neurotherapeutics·Hussam Seif-Eddeine, Yu-Tze Ng
Apr 8, 2020·World Journal of Gastroenterology : WJG·Tomislav KelavaAnna Mrzljak
Oct 8, 2020·British Journal of Clinical Pharmacology·Marith I FranckeBrenda C M de Winter

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.